Adelson M D
Department of Obstetrics and Gynecology, State University of New York Health Science Center.
Gynecol Oncol. 1991 Jun;41(3):220-2. doi: 10.1016/0090-8258(91)90312-s.
The Cavitron Ultrasonic Surgical Aspirator was used to reduce the volume of diaphragmatic metastases in 33 patients. Thirty patients had epithelial carcinoma of the ovary and one each had tubal adenocarcinoma, papillary peritoneal tumor, and mesothelioma. Twenty-seven patients had Stage IIIC disease, and six had Stage IV. Initially, 13 patients had diaphragmatic disease greater than 15 mm diameter (of any single nodule), and 2 had disease 6-15 mm diameter. After cytoreduction using standard means, 11 patients had disease greater than 15 mm diameter and 2 patients had disease from 6 to 15 mm in greatest diameter. After using the Cavitron, 1 patient had no gross diaphragmatic residual disease, and 30 patients had disease 1-5 mm diameter. No complication resulted from the cytoreduction of diaphragm disease using the Cavitron. The Cavitron Ultrasonic Surgical Aspirator is invaluable to obtain minimal residual disease of diaphragmatic metastases.
使用Cavitron超声手术吸引器减少了33例患者膈转移灶的体积。30例为卵巢上皮癌，1例为输卵管腺癌，1例为乳头状腹膜肿瘤，1例为间皮瘤。27例为IIIC期疾病，6例为IV期。最初，13例患者的膈疾病直径大于15mm（任何单个结节），2例患者的疾病直径为6 - 15mm。采用标准方法进行肿瘤细胞减灭术后，11例患者的疾病直径大于15mm，2例患者的疾病最大直径为6至15mm。使用Cavitron后，1例患者无肉眼可见的膈残留疾病，30例患者的疾病直径为1 - 5mm。使用Cavitron进行膈疾病的肿瘤细胞减灭术未引起并发症。Cavitron超声手术吸引器对于获得膈转移灶的最小残留疾病非常重要。
